Drug Trial Radar · NCT04770610
Study of OT-101 in Treating Myopia
Last checked: Nov 20, 2026Latest source record: Aug 8, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
678
Planned (sponsor's estimate)
Start
Apr 1, 2021
Primary completion
Mar 2027
Study completion Apr 2027
Sponsor
- Lead sponsor
- Ocumension (Hong Kong) LimitedAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- ORA, Inc.; Statistics & Data Corporation
- First posted
- Feb 25, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 3 years, up to 15 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase III, randomized, double-masked, placebo-controlled, parallel-group, multicenter safety, tolerability, and efficacy study of atropine sulfate 0.01% (OT-101) as an investigational treatment for myopia in pediatric subjects
Conditions
- Myopia, Progressive
Interventions
OT-101 Ophthalmic SolutionDrug
Atropine 0.01%
VehicleDrug
Investigational Product minus active ingredient
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of study eyes with a -0.75D of progressive myopia defined as an increase in spherical equivalent of -0.75D or greater as assessed by cycloplegic autorefraction.Time frame: At month 36
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
Colorado Vision Institute
Colorado Springs, Colorado
Eye Center of Northern Colorado, PC
Fort Collins, Colorado
Family Focus
Gainesville, Florida
Pediatric Eye Consultants of North Florida
Jacksonville, Florida
Indiana University Health Physicians Pediatric Ophthalmology
Indianapolis, Indiana
Kids Eye Care of Maryland
Rockville, Maryland
Comprehensive Eye Care, Ltd.
Washington, Missouri
Pure Ophthalmic Research
Mint Hill, North Carolina
CORE, Inc.
Shelby, North Carolina
University Hospitals Cleveland Medical Center
Cleveland, Ohio
Scott & Christie and Associates
Cranberry Township, Pennsylvania
Pediatric Ophthalmology of Erie, Inc
Erie, Pennsylvania
UPMC Children's Hospital
Pittsburgh, Pennsylvania
Total Eye Care, P.A.
Memphis, Tennessee
San Antonio Eye Center
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.